GALIMBERTI STEFANIA
Ruolo:
Professore ordinario
Settore scientifico disciplinare:
STATISTICA MEDICA (MED/01)
E-mail:
Telefono:
0264488164
Didattica
A.A.: 2019/2020
A.A.: 2018/2019
A.A.: 2017/2018
A.A.: 2016/2017
Pubblicazioni
- Piga, I., Capitoli, G., Tettamanti, S., Denti, V., Smith, A., Chinello, C., et al. (2019). Feasibility study for the MALDI-MSI analysis of thyroid fine needle aspiration biopsies: evaluating the morphological and proteomic stability over time. PROTEOMICS. CLINICAL APPLICATIONS, 13(1). Dettaglio
- Marktel, S., Scaramuzza, S., Cicalese, M., Giglio, F., Galimberti, S., Lidonnici, M., et al. (2019). Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. NATURE MEDICINE, 25(2), 234-241. Dettaglio
- Ferrua, F., Galimberti, S., Courteille, V., Slatter, M., Booth, C., Moshous, D., et al. (2019). Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Dettaglio
- Ferrua, F., Cicalese, M., Galimberti, S., Giannelli, S., Dionisio, F., Barzaghi, F., et al. (2019). Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study. THE LANCET. HAEMATOLOGY, 6(5), e239-e253. Dettaglio
- Galimberti, S., Capitoli, G., Rotolo, F., & Valsecchi, M. (2019). New approaches for the validation of a highly skewed surrogate for a survival endpoint. Intervento presentato a: Annual Conference of the International Society for Clinical Biostatistics ISCB40, Leuven, Belgium. Dettaglio
